Advertisement
News
Subscribe to MDT Magazine News

Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing

February 23, 2011 5:38 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass., Feb. 23, 2011 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris' acoustic DNA shearing platforms and Caliper's automation and microfluidics technologies to develop...

TOPICS:

Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lynâ„¢ in the United States

February 23, 2011 5:38 am | by Bio-Medicine.Org | Comments

WORCESTER, Mass., Feb. 23, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin Board: GNBT ) announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration (FDA) Expanded Access Treatment Investigational New Drug...

TOPICS:

Healthpoint Launches New Corporate Identity

February 23, 2011 5:38 am | by Bio-Medicine.Org | Comments

FORT WORTH, Texas, Feb. 23, 2011 /- Healthpoint today announced the launch of a new corporate identity featuring a new company name, Healthpoint Biotherapeutics, along with an updated brandmark and corporate tagline, "The Science of Healing™". Together, the new corporate identity is...

TOPICS:
Advertisement

Sunridge Signs Distribution Agreement for Turkey

February 23, 2011 5:38 am | by Bio-Medicine.Org | Comments

FOUNTAIN HILLS, Ariz., Feb. 23, 2011 /- Sunridge International (OTC Bulletin Board/OTCQB: SNDZ), announced today the signing of an exclusive distribution contract for Turkey.  Based on Turkey's population of approximately 75 million people, the 5-year contract with New Amsterdam...

TOPICS:

St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions

February 23, 2011 5:38 am | by Bio-Medicine.Org | Comments

CHICAGO and ORANGE, Calif., Feb. 23, 2011 /- St. Joseph Health System (SJHS), a $4.6 billion not-for-profit Catholic healthcare system based in Orange, CA that provides a broad range of medical services in California, West Texas and Eastern New Mexico, has selected Care Management™...

TOPICS:

Speck Design Delivers Solutions for Two Complex Consumer Products for Social Good

February 23, 2011 5:37 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Feb. 23, 2011 /- Complications during development led two product development companies to turn to Speck Design in recent months for an inventive approach and mechanical design that would deliver top-quality products on deadline.  The first product, Zamzee, had an...

TOPICS:

Avanir Pharmaceuticals to Present at Three Conferences in March

February 23, 2011 5:36 am | by Bio-Medicine.Org | Comments

ALISO VIEJO, Calif., Feb. 23, 2011 /- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR ) today announced that company management will present an overview of the company at the following conferences in March. Citi 2011 Global Healthcare Conference Location: Hilton New York, New York, NY...

TOPICS:

Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference

February 23, 2011 5:35 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., Feb. 23, 2011 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the RBC Capital Markets' Healthcare Conference on...

TOPICS:
Advertisement

European Multidisciplinary Conference in Thoracic Oncology -- press program

February 23, 2011 5:35 am | by EurekAlert | Comments

(European Society for Medical Oncology) The following studies will be presented in the Press Program of the second European Multidisciplinary Conference in Thoracic Oncology, a multipartner initiative for physicians of all medical disciplines dealing with lung cancer and other thoracic malignancies.

TOPICS:

Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation

February 23, 2011 5:35 am | by Bio-Medicine.Org | Comments

BETHESDA, Md., Feb. 23, 2011 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis, showed promising results in a Phase 3 clinical...

TOPICS:

Medical Device Safety Tip: Infant Phototherapy Light

February 23, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

FDA received a report about a brown area on the lens cover of an infant phototherapy light. Upon closer examination, the lens cover also had burned and melted areas from having been improperly positioned under the heating element of an infant warmer...

TOPICS:

MAP Pharmaceuticals to Present at Upcoming Investor Conferences

February 23, 2011 3:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Feb. 23, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the Company will participate in the following investor conferences in March: Citi's 2011 Global Healthcare Conference Wednesday, March 2, at 3:30 p.m. ET in New YorkRBC Capital Markets'...

TOPICS:

Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study

February 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Feb. 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein (CRP) in the cohort of subjects in the study with elevated CRP....

TOPICS:

Reportlinker Adds Global Medical Ultrasound Equipment Industry

February 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Ultrasound Equipment Industry http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html This report analyzes the worldwide...

TOPICS:

Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

February 23, 2011 3:33 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., Feb. 23, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that it will host a conference call on Thursday, March 10th, 2011, at 8:30 AM EST, to discuss its financial results for the fourth quarter and year-end 2010.  Insmed...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading